(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
This book serves as a reference text for regulatory, industry and academic statisticians and also a handy manual for entry level Statisticians. Additionally it aims to stimulate academic interest in the field of Nonclinical Statistics and promote this as an important discipline in its own right. This text brings together for the first time in a single volume a comprehensive survey of methods important to the nonclinical science areas within the pharmaceutical and biotechnology industries. Specifically the Discovery and Translational sciences, the Safety/Toxiology sciences, and the Chemistry, Manufacturing and Controls sciences. Drug discovery and development is a long and costly process. Most decisions in the drug development process are made with incomplete information. The data is rife with uncertainties and hence risky by nature. This is therefore the purview of Statistics. As such, this book aims to introduce readers to important statistical thinking and its application in these nonclinical areas. The chapters provide as appropriate, a scientific background to the topic, relevant regulatory guidance, current statistical practice, and further research directions.
Contents:
Introduction to Nonclinical Statistics for Pharmaceutical and Biotechnology Industries.- Regulatory Nonclinical Statistics.- How to be a good nonclinical statistician.- Statistical Methods for Drug Discovery.- High-throughput Screening Data Analysis.- Quantitative-Structure Activity Relationship Modeling and Cheminformatics.- GWAS for Drug Discovery.- Statistical applications in Design and Analysis of In-Vitro Safety Screening Assays.- Nonclinical safety assessment: an introduction for statisticians.- General Toxicology, Safety Pharmacology, Reproductive Toxicology and Juvenile Toxicology Studies.- Clinical Assays for Biological Macromolecules.- Recent Research Projects by FDA's Pharmacology and Toxicology Statistics Team.- Design and evaluation of drug combination studies.- Biomarkers.- Overview of Drug Development and Statistical Tools for Manufacturing and Testing.- Assay Validation.- Lifecycle Approach to Bioassay.- Quality by Design: Building Quality into Products and Processes.- Process Validation.- Acceptance Sampling.- Process Capability and Statistical Process Control.- Statistical Considerations for Stability and the Estimation of Shelf Life.- In Vitro Dissolution Testing: Statistical Approaches and Issues.- Assessing Content Uniformity.- Chemometrics and Predictive Modelling.- Statistical Methods for Comparability Studies.
PRODUCT DETAILS
Publisher: Springer (Springer International Publishing AG)
Publication date: January, 2016
Pages: 300
Weight: 652g
Availability: Available
Subcategories: Epidemiology, General Practice, Pharmacology
From the same series
Daniel Zelterman
Bibhas Chakraborty
Antonella Bacchieri
Thomas Hamelryck
Eric Vittinghoff
Klaus Krickeberg
Jong-Hyeon Jeong
Bibhas Chakraborty
Giovanni Parmigiani
Nan M. Laird
Philip Hougaard
Annette J. Dobson
Toshiro Tango
Alexander Eric Kramer
Thomas Hamelryck
Richard M. Simon
Karl W. Broman
Klaus Krickeberg
Eric Vittinghoff
David G. Kleinbaum
Timothy L. Lash
Joel Cohen
Nan M. Laird
John P. Klein
Ewout Steyerberg
Daniel Sorensen
Lemuel A. Moye
Kenneth G. Manton
Warren J. Ewens
Rongling Wu
Odd Aalen
Richard J. Cook
Naitee Ting
David Siegmund
Nicole A. Lazar
Luc Duchateau
Peter Schlattmann
David G. Kleinbaum
Adrian Barnett
Toshiro Tango
Alexander Eric Kramer
Claudio Jose Struchiner
Karl W. Broman
Timothy L. Lash
Peter Schlattmann
Kenneth G. Manton
Ewout W. Steyerberg
Odd Aalen
Nicole A. Lazar
Luc Duchateau
Richard J. Cook
Rongling Wu
Daniel Sorensen
David Siegmund
Antonella Bacchieri
Naitee Ting